Source 1review2016Nature reviews. Cancer
Toolkit/nab-paclitaxel
nab-paclitaxel
Also known as: albumin-bound paclitaxel, nanoparticle albumin-bound paclitaxel
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
The web research summary identifies albumin-bound paclitaxel as an exemplar nanomedicine modality already used or tested clinically and explicitly names nab-paclitaxel as a clinically relevant nanomedicine example.
Usefulness & Problems
Why this is useful
Nab-paclitaxel is presented in the supplied evidence as an albumin-bound nanoparticle formulation of paclitaxel used as a cancer nanomedicine example. It serves as a concrete exemplar of nanomedicine applied in oncology.; example of a clinically relevant cancer nanomedicine formulation; illustrating albumin-bound nanoparticle drug delivery in oncology
Source:
Nab-paclitaxel is presented in the supplied evidence as an albumin-bound nanoparticle formulation of paclitaxel used as a cancer nanomedicine example. It serves as a concrete exemplar of nanomedicine applied in oncology.
Source:
example of a clinically relevant cancer nanomedicine formulation
Source:
illustrating albumin-bound nanoparticle drug delivery in oncology
Problem solved
It addresses the need to formulate and deliver an anticancer drug within a nanomedicine framework. In this extraction, its main value is as a clinically relevant reference point for cancer nanomedicine.; packages paclitaxel in an albumin-bound nanoparticle formulation for cancer treatment
Source:
It addresses the need to formulate and deliver an anticancer drug within a nanomedicine framework. In this extraction, its main value is as a clinically relevant reference point for cancer nanomedicine.
Source:
packages paclitaxel in an albumin-bound nanoparticle formulation for cancer treatment
Problem links
packages paclitaxel in an albumin-bound nanoparticle formulation for cancer treatment
LiteratureIt addresses the need to formulate and deliver an anticancer drug within a nanomedicine framework. In this extraction, its main value is as a clinically relevant reference point for cancer nanomedicine.
Source:
It addresses the need to formulate and deliver an anticancer drug within a nanomedicine framework. In this extraction, its main value is as a clinically relevant reference point for cancer nanomedicine.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Techniques
Selection / EnrichmentTarget processes
selectionImplementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: payload burdenoperating role: regulator
Use of this formulation requires paclitaxel packaged in an albumin-bound nanoparticle format and the associated drug-development and delivery infrastructure. The provided payload does not specify further operational requirements from the anchor review itself.; requires an albumin-bound nanoparticle formulation of paclitaxel; clinical or translational use depends on oncology drug-delivery and manufacturing context not detailed in the provided anchor-review text
The provided evidence does not show that it solves the broader delivery and translation barriers discussed for cancer nanomedicine in general. No anchor-review text is provided here to support stronger claims about overcoming tumor-delivery limitations.; the provided payload does not include anchor-review text detailing comparative efficacy, safety, or mechanistic limits
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
The topic scope includes exemplar nanomedicine modalities already used or tested clinically, including albumin-bound paclitaxel.
The anchor article is a 2017 Nature Reviews Cancer review on cancer nanomedicine that emphasizes three recurring enrichment themes ... (3) exemplar nanomedicine modalities already used or tested clinically, such as albumin-bound paclitaxel.
Approval Evidence
1 source1 linked approval claimfirst-pass slug nab-paclitaxel
The web research summary identifies albumin-bound paclitaxel as an exemplar nanomedicine modality already used or tested clinically and explicitly names nab-paclitaxel as a clinically relevant nanomedicine example.
Source:
example modalitysupports
The topic scope includes exemplar nanomedicine modalities already used or tested clinically, including albumin-bound paclitaxel.
The anchor article is a 2017 Nature Reviews Cancer review on cancer nanomedicine that emphasizes three recurring enrichment themes ... (3) exemplar nanomedicine modalities already used or tested clinically, such as albumin-bound paclitaxel.
Source:
Comparisons
Source-stated alternatives
The supplied evidence frames nab-paclitaxel as one exemplar among broader cancer nanomedicine modalities. Other specific alternatives are not explicitly named in the anchor-review payload.
Source:
The supplied evidence frames nab-paclitaxel as one exemplar among broader cancer nanomedicine modalities. Other specific alternatives are not explicitly named in the anchor-review payload.
Source-backed strengths
presented as a clinically relevant exemplar within cancer nanomedicine
Source:
presented as a clinically relevant exemplar within cancer nanomedicine
Compared with CaMKIIα promoter-based targeting
nab-paclitaxel and CaMKIIα promoter-based targeting address a similar problem space because they share selection.
Shared frame: same top-level item type; shared target processes: selection
Compared with inkube
nab-paclitaxel and inkube address a similar problem space because they share selection.
Shared frame: same top-level item type; shared target processes: selection
Compared with synthetic promoters
nab-paclitaxel and synthetic promoters address a similar problem space because they share selection.
Shared frame: same top-level item type; shared target processes: selection
Relative tradeoffs: appears more independently replicated; looks easier to implement in practice.
Ranked Citations
- 1.